Add time:07/26/2019         Source:sciencedirect.com

N-[5-[N-(2-Amino-5-chloro-3,4-dihydro-4-oxoquinazolin-6-yl)methylamino]-2-thenoyl]-l-glutamic acid (Figure 1, Scheme 2) and N-[5-[N-(5-chloro-3,4-dihydro-2-methyl-4-oxoquinazolin-6-yl)methylamino]-2-thenoyl]-l-glutamic acid (Figure 1, Scheme 3), the first reported thiophene analogues of 5-chloro-5,8-dideazafolic acid, were synthesized and tested as inhibitors of tumor cell growth in culture. 4-Chloro-5-methylisatin (10) was converted stepwise to methyl 2-amino-5-methyl-6-chlorobenzoate (22) and 2-amino-5-chloro-3,4-dihydro-6-methyl-4-oxoquinazoline (19). Pivaloylation of the 2-amino group, followed by NBS bromination, condensation with di-tert-butyl N-(5-amino-2-thenoyl)-l-glutamate (28), and stepwise cleavage of the protecting groups with ammonia and TFA yielded Figure 1, Scheme 2. Treatment of 9 with acetic anhydride afforded 2,6-dimethyl-5-chlorobenz[1,3-d]oxazin-4-one (31), which on reaction with ammonia, NaOH was converted to 2,6-dimethyl-5-chloro-3,4-dihydroquinazolin-4-one (33). Bromination of 33, followed by condensation with 28 and ester cleavage with TFA, yielded Figure 1, Scheme 3. The IC50 of Figure 1, Scheme 2 and Figure 1, Scheme 3 against CCRF-CEM human leukemic lymphoblasts was 1.8±0.1 and 2.1±0.8 μM, respectively.

We also recommend Trading Suppliers and Manufacturers of 2-desamino-2-trifluoromethyl-N(10)-propargyl-5,8-dideazafolic acid (cas 112887-78-2). Pls Click Website Link as below: cas 112887-78-2 suppliers